NHMRC Clinical Trials Centre: Recent submissions
-
Performance of long-term CT and PET/CT surveillance for detection of distant recurrence in patients with resected stage IIIA-D melanoma
Published 2021Background Follow-up for patients with resected stage IIIA–D melanoma may include computed tomography (CT) or positron emission tomography (PET)/CT imaging to identify distant metastases. The aim of this study was to ...Open AccessArticle -
Symptom monitoring With Feedback trial (SWIFT) dataset
Published 2023-05-19This dataset contains the Patient Reported Outcome Measures (PROMs) of the SWIFT participants, a cohort of 2422 satellite dialysis patients clustered into 143 centres across Australia. The PROMs data are the EQ-5D-5L ...Dataset -
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Published 2019Globally, the number of patients undergoing maintenance dialysis is increasing, yet throughout the world there is significant variability in the practice of initiating dialysis. Factors such as availability of resources, ...Open AccessArticle -
The Fenofibrate And Microvascular Events in Type 1 diabetes Eye (FAME 1 EYE) dataset
Published 2023-05-03The estimated sample size is 450. Demographics, clinical characteristics and outcomes measures will be available from patients with type 1 diabetes. All timepoints points (baseline, 6-week, 3-month, 6-month, 1-year, 2-year, ...Open AccessDataset -
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
Published 2021Background Most subsequent new primary or recurrent melanomas might be self-detected if patients are trained to systematically self-examine their skin and have access to timely medical review (patient-led surveillance). ...Open AccessArticle